Chemours (CC) Scheduled to Post Earnings on Monday

Chemours (NYSE:CC) will issue its quarterly earnings data before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of $0.32 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Chemours (NYSE:CC) last posted its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $0.38 earnings per share for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.19). The business had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.53 billion. Chemours had a net margin of 2.16% and a return on equity of 33.21%. The firm’s quarterly revenue was down 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.10 earnings per share. On average, analysts expect Chemours to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Chemours Stock Down 1.9 %

Shares of NYSE CC opened at $17.82 on Friday. Chemours has a 1 year low of $15.10 and a 1 year high of $32.70. The company has a market capitalization of $2.66 billion, a price-to-earnings ratio of 22.00 and a beta of 1.74. The company has a debt-to-equity ratio of 5.45, a current ratio of 1.89 and a quick ratio of 1.01. The business has a 50-day moving average of $18.95 and a two-hundred day moving average of $22.28.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be given a dividend of $0.25 per share. The ex-dividend date is Friday, November 15th. This represents a $1.00 annualized dividend and a dividend yield of 5.61%. Chemours’s dividend payout ratio is presently 123.46%.

Analyst Ratings Changes

CC has been the topic of a number of research reports. UBS Group dropped their price target on Chemours from $30.00 to $28.00 and set a “buy” rating on the stock in a research note on Tuesday, August 6th. BMO Capital Markets raised their target price on shares of Chemours from $30.00 to $32.00 and gave the stock an “outperform” rating in a research report on Monday, October 7th. Barclays reduced their price target on shares of Chemours from $22.00 to $21.00 and set an “equal weight” rating for the company in a research report on Wednesday, September 25th. Royal Bank of Canada decreased their price target on shares of Chemours from $35.00 to $28.00 and set an “outperform” rating for the company in a research note on Friday, October 11th. Finally, The Goldman Sachs Group dropped their price objective on shares of Chemours from $29.00 to $23.00 and set a “neutral” rating on the stock in a research note on Tuesday, September 3rd. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $25.00.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.